E776-1733 Screening compound: N-[2-(cyclohex-1-en-1-yl)ethyl]-4-{5-methyl-4-[(4-methylbenzenesulfonyl)methyl]-1,3-oxazol-2-yl}benzamide

E776-1733 Screening compound: N-[2-(cyclohex-1-en-1-yl)ethyl]-4-{5-methyl-4-[(4-methylbenzenesulfonyl)methyl]-1,3-oxazol-2-yl}benzamide
E776-1733 Screening compound: N-[2-(cyclohex-1-en-1-yl)ethyl]-4-{5-methyl-4-[(4-methylbenzenesulfonyl)methyl]-1,3-oxazol-2-yl}benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E776-1733
N-[2-(cyclohex-1-en-1-yl)ethyl]-4-{5-methyl-4-[(4-methylbenzenesulfonyl)methyl]-1,3-oxazol-2-yl}benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E776-1733

Molecular Formula

C27H30N2O4S (C27 H30 N2 O4 S)

Compound Name

N-[2-(cyclohex-1-en-1-yl)ethyl]-4-{5-methyl-4-[(4-methylbenzenesulfonyl)methyl]-1,3-oxazol-2-yl}benzamide

IUPAC name

N-[2-(cyclohex-1-en-1-yl)ethyl]-4-{5-methyl-4-[(4-methylbenzenesulfonyl)methyl]-13-oxazol-2-yl}benzamide

SMILES

Cc1c(CS(c2ccc(C)cc2)(=O)=O)nc(-c(cc2)ccc2C(NCCC2=CCCCC2)=O)o1

InChI

InChI=1S/C27H30N2O4S/c1-19-8-14-24(15-9-19)34(31,32)18-25-20(2)33-27(29-25)23-12-10-22(11-13-23)26(30)28-17-16-21-6-4-3-5-7-21/h6,8-15H,3-5,7,16-18H2,1-2H3,(H,28,30)

InChI Key

CERANMVNRPIOLS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14918111

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

478.61

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.610

Distribution Coefficient, logD

4.610

Water Solubility, LogSw

-4.24

Polar Surface Area

71.572

Acid Dissociation Constant (pKa)

13.82

Base Dissociation Constant (pKb)

-2.82

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

E776-1733 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • GPCR
  • Phosphatases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with E776-1733 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E776-1733?
Check Price and Availability of E776-1733, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E776-1733 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E776-1733
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E776-1733
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E776-1733 available by request